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INTRODUCTION
Sea lice are aquatic ectoparasitic copepods of the
family Caligidae and feed on the mucus, skin and
blood of the host fish. While low level infestations of
sea lice cause only minimal effects on the host, high
numbers can result in progressively worsening skin
damage and even death of the host. As early as 1940,
there were reports of high numbers of lice causing
severe damage and mortality in wild fish (White
1940). Intensive salmon farming, particularly where
fish farms are clustered in regions, can contribute to
outbreaks of pathogens and, potentially, to clinical
disease (Murray & Peeler 2005, Robertsen 2011).
Lack of adequate control over sea lice populations
can result in a number of economic impacts on fish
producers. In addition to mortalities related to sea
lice infestation and the cost of parasiticides, other
factors, such as increased personnel costs, reduction
in food conversion efficiency, reduced fish growth
and mortalities secondary to treatment, contribute to
economic losses (Costello 2009).
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ABSTRACT: Emamectin benzoate (an avermectin chemotherapeutant administered to fish as an
in-feed treatment) has been used to treat infestations of sea lice Lepeophtheirus salmonis on
farmed Atlantic salmon Salmo salar in the Bay of Fundy, New Brunswick, Canada, since 1999.
This retrospective study examined the effectiveness of 114 emamectin benzoate treatment
episodes from 2004 to 2008 across 54 farms. Study objectives were to establish whether changes
in the effectiveness of emamectin benzoate were present for this period, examine factors associ-
ated with treatment outcome, and determine variables that influenced differences in L. salmonis
abundance after treatment. The analysis was carried out in 2 parts: first, trends in treatment effec-
tiveness and L. salmonis abundance were explored, and second, statistical modelling (linear and
logistic regression) was used to examine the effects of multiple variables on post-treatment abun-
dance and treatment outcome. Post-treatment sea lice abundance increased in the later years
examined. Mean abundance differed between locations in the Bay of Fundy, and higher numbers
were found at farms closer to the mainland and lower levels were found in the areas around Grand
Manan Island. Treatment effectiveness varied by geographical region and decreased over time.
There was an increased risk for unsuccessful treatments in 2008, and treatments applied during
autumn months were more likely to be ineffective than those applied during summer months.
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There are 2 genera of sea lice commonly found
on salmonids in marine and brackish waters: Le -
peo ph theirus and Caligus. Major species associated
with salmon aquaculture along the east coast of
Canada and the USA are L. salmonis and C. elon-
gatus (Boxaspen 2006). L. salmonis is the more
pathogenic species in the Bay of Fundy, New
Brunswick, Canada, mostly due to its size and
aggressive feeding in the later stages of its life
cycle. L. salmonis has a 10-stage life cycle with a
moult between each stage. There is a free-swim-
ming phase consisting of 2 naupliar and 1 copepo-
did stages. The copepodid settles on the host fish
to begin the attached phase and will then moult
through 4 chali mus, 2 pre-adult and 1 adult stage
(Johnson & Albright 1991a, Schram 1993). Johnson
& Albright (1991b) reported the generation time to
be 40 d for adult males and 52 d for adult females
at 10°C (time from egg to adult stage).
Salmon farming is a 2 phase production system
usually consisting of land-based, freshwater hatch-
ery and marine cage site phases. Fish are transferred
from the hatchery as smolts to sea cages, which can
occur anywhere from 1 to 2 yr after egg hatching.
Fish will be harvested approximately 18 to 24 mo
after transfer to sea cages. In New Brunswick, smolts
are normally transferred in the spring (April to June)
or fall (November to December), and the majority of
the fish are transferred during the spring months.
Sea lice are a problem during only the marine cage
stage of the production cycle.
Emamectin benzoate (SLICE®) is an avermectin
chemotherapeutant administered to fish as an in-
feed treatment (reviewed by Horsberg 2012). Ema -
mectin benzoate can be effective against Lepeo ph -
theirus salmonis on farmed Atlantic salmon Salmo
salar in North America (Armstrong et al. 2000, Gus -
tafson et al. 2006, Saksida et al. 2007). Several stud-
ies have examined the efficacy of emamectin ben-
zoate in Maine (USA), Scotland (UK) and British
Columbia (Canada) (Gustafson et al. 2006, Lees et
al. 2008a,b, Saksida et al. 2010). In Maine, all treat-
ments that were applied appeared to be efficacious;
however, the study did not assess changes in effec-
tiveness over the study period of 2002 to 2005
(Gustafson et al. 2006). Examination of emamectin
benzoate use in British Columbia found no decrease
in effectiveness from 2003 to 2008 (Saksida et al.
2010). A decline in efficacy was reported in Scotland
during the years examined, 2002 to 2006 (Lees et al.
2008a,b). On the east coast of Canada, a recent
investigation using laboratory bioassays found
increases in EC50 (effective concentration) values for
emamectin benzoate in L. salmonis from southwest-
ern New Bruns wick collected in 2011 (Igboeli et al.
2012) compared with values from 2002 to 2005
(Westcott et al. 2008). A reduction in the sensitivity
of Caligus rogercresseyi to emamectin benzoate
based on laboratory bioassays has been documented
in Chile (Bravo et al. 2008).
In New Brunswick, control of sea lice became a
problem in the mid-1990s when there was a con-
sistent increase in the abundance of sea lice found
on farmed Atlantic salmon. Initially the majority of
sea lice on farmed salmon were Caligus spp., but
Lepeophtheirus salmonis later became the pre-
dominant species and remains so to the present
(Hogans & Trudeau 1989, Hogans 1995). In the fall
of 1994, an outbreak of L. salmonis occurred on
salmon farms in the Lime Kiln and Back Bay areas
of southwestern New Brunswick (Hogans 1995).
Around that time, a multitude of treatments, in -
cluding hydrogen per oxide, ivermectin and aza-
methiphos, were attempted with varying success
(Hogans 1995, O’Halloran & Hogans 1996). Ema -
mectin benzoate was introduced in New Brunswick
in 1999 through an emergency drug release (Arm-
strong et al. 2000). This product became the treat-
ment of choice for several reasons: effectiveness
against all life stages, prolonged effect, and ease
of administration in feed (Stone et al. 2000a,b). Be -
cause emamectin benzoate was an effective treat-
ment, there was little incentive to seek approval
for other sea lice treatment agents, resulting in this
product being used for the majority of sea lice
treatments. After almost a decade of use, isolated
treatment failures were observed in late 2008,
resulting in suspicions about changes in sea lice
sensitivity to emamectin benzoate. During 2009, it
became evident that a more serious problem was
occurring, which compelled industry and govern-
ment to investigate other methods of treatment for
sea lice (Chang et al. 2011).
The focus of the present study was to examine
emamectin benzoate treatment effects on Lepeo ph -
theirus salmonis. The objectives of this retrospective
analysis were to establish whether changes in
 effectiveness of emamectin benzoate were present
from 2004 to 2008, examine factors associated with
treatment outcome (effective or ineffective), and as -
certain which variables influenced differences in
post-treatment L. salmonis abundance. A cross sec-
tion of data obtained from health records collected by
salmon farms in the Bay of Fundy region of south-
western New Brunswick from 2004 to 2008 was
examined.
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MATERIALS AND METHODS
Data set
The Bay of Fundy is located on the east
coast of Canada between New Brunswick
and Nova Scotia and shares water with Cob-
scook Bay, Maine, USA (Fig. 1). The area of
interest for this study was along the New
Brunswick coast of the Bay of Fundy where
Atlantic salmon farming represents a major
aquaculture activity. A bay management
system is used for the location and stocking
of fish farms, called Aquaculture Bay Man-
agement Areas (ABMA) (Fig. 1). The 8 ABMAs as
they were established in 2006 are shown in Fig. 1. In
2010, ABMA 4 was incorporated into ABMA 1, and
for the purpose of this study that change was used
for all years examined. Data were available from
5 ABMAs (Table 1): (1) Passa ma quoddy Bay (includ-
ing sites around Deer Island and Campobello Island);
(2a) Lime Kiln Bay and Back Bay; (3a) the area con-
sidered the ‘up shore region’ heading east towards
the city of Saint John (including areas such as Beaver
Harbour and Maces Bay); and finally (2b and 3b) 2
areas that are both located on the eastern side of
Grand Manan Island. These 5 ABMAs contained the
majority of active salmon farms. There were no qual-
ifying treatment episodes in ABMAs 5 or 6, but since
only a few salmon farms are located in these areas,
this was not expected to affect this study’s conclu-
sions. For part of this analysis (statistical models),
ABMAs 2b and 3b, located around Grand Manan
Island, were grouped together since they are adja-
cent to each other and relatively far removed from
the other ABMAs.
The data used in this study were extracted from
records collected and maintained for sea lice man-
agement purposes by the veterinary services within
Cooke Aquaculture and Maritime Veterinary Serv-
ices. These records were associated with just over
one-half of the fish farming sites and the majority of
the companies operating in this region for the period
under examination.
Regular sea lice counts are a rou-
tine part of salmon farming in this
region, as is the case for most salmon
farming areas around the world, and
counts typically occur at least every
second week. A number of fish are
opportunistically sampled by attrac -
ting them to the water surface with
feed and capturing them with a
hand net. Fish are anesthetized in a
water bath with tricaine me tha -
nesulfonate added, and when fish
are sufficiently immobilized the sea
lice are counted and classified by us-
ing the following life stages: chal-
imus, pre-adult females, pre-adult
males, adult males and adult females
(gra vid or non-gravid). How ever,
pre-adult males and pre-adult fe-
males are often combined with adult
males in re cords to form one cate-
gory. In this particular study, we ex-
amined only Lepeophtheirus salmo-
nis as this is the more pathogenic
55
ABMA Location No. of treatments
Qualifying Effective (%)
1 Passamaquoddy Bay and 46 38 (82.6)
Deer and Campobello Islands
2a Lime Kiln, Back Bay 26 16 (61.5)
2b Grand Manan Island 7 7 (100)
3a Maces Bay 20 18 (90.0)
3b Grand Manan Island 15 15 (100)
Table 1. Summary of qualifying emamectin benzoate treatment
episodes for sea lice Lepeophtheirus salmonis that occurred in each
Aquaculture Bay Management Area (ABMA) of the Bay of Fundy 
(2004 to 2008)
Fig. 1. Aquaculture Bay Management Areas for the southwestern New Bruns -
wick Bay of Fundy salmon farming region (salmon farm leases for 2010 are 
indicated). Map produced by B. Chang
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and far more prevalent species found on farmed
 Atlantic salmon in the Bay of Fundy (Hogans 1995).
Treatment episode selection
The study design and methodology used in this in-
vestigation was similar to methods used in Lees et al.
(2008a,b) in Scotland. Historical sea lice count data
and treatment records were examined from 2004 to
2008 and treatment episodes were selected based on
specific study inclusion criteria. To be included, a
treatment episode had to contain a pre-treatment
count within 16 d of treatment being started, as well
as a minimum of 3 post-treatment sea lice evaluations
in the 12 wk after initiation of treatment. If there was
more than one pre-treatment count available in the
16 d period, then the count closest to the date of treat-
ment initiation was used. A specific sea lice count was
only included when at least 2 cages were sampled
and a minimum of 5 fish per cage were examined.
Treatment of sea lice with emamectin benzoate in-
volves the administration of medicated fish feed over
the course of 7 d. Any treatment that had a notation in
the record regarding only partial site treatment or
split-site treatment was excluded from this analysis.
For this analysis, pre-adult males, adult males, pre-
adult females and adult females (gravid and non-
gravid) Lepeophtheirus sal monis were aggregated
into a single group called ‘total mobiles’.
Treatment trends and effectiveness
The analysis was split into 2 parts: first, description
of treatment effectiveness and trends in Lepeoph-
theirus salmonis abundance, and second, statistical
modelling (linear and logistic regression) to examine
the effects of multiple variables on post-treatment
mean mobile L. salmonis abundance and treatment
outcome. For the former, treatment trends were sum-
marized at the farm level and examined by year in
2 ways: first, mean abundance of total mobiles before
and after treatment, and second, treatment effective-
ness as a percentage of the pre-treatment abun-
dance. Pre-treatment mean abundance of mobile
L. salmonis varied by year and this variance was
examined by use of an ANOVA procedure. For com-
parisons of means, a post-ANOVA multiple compar-
isons procedure was performed using the Bonferroni
method. Treatment effectiveness was determined
as (post-treatment mean abundance/pre-treatment
mean abundance) × 100. 
A treatment was considered effective if the post-
treatment mean abundance fell to less than 40% of
the pre-treatment mean abundance at any point dur-
ing the post-treatment period. This value has been
used in previous studies as a cut-off point upon
which to base treatment success with emamectin
benzoate (Lees et al. 2008a,b, Saksida et al. 2010).
Statistical modelling
The second part of the analysis involved the build-
ing of 2 statistical models: a linear model for post-
treatment mean mobile Lepeophtheirus salmonis
abundance, and a logistic model of treatment effec-
tiveness. Predictor variables used in the building
of the statistical models were year, pre-treatment
mean mobile L. salmonis abundance, location of farm
(ABMA), season, month, season2 (see below), age of
fish and season of smolt transfer, as well as the week
of count during the post-treatment period. Fish were
classified into first or second production year based
on the age of fish since their transfer as smolts to
ocean cages. Fish were classified as first-year fish if
they had been at sea for less than 365 d and as sec-
ond-year fish if they were at sea for more than 365 d.
Fish were also classified into groups based on the
season of smolt transfer, either spring or autumn.
Since temperature and season can be important fac-
tors in relation to sea lice abundance, the variables
month, season and season2 were created to examine
their potential impact on post-treatment L. salmonis
abundance. The month of treatment application was
used as a predictor, along with a season variable cre-
ated by categorizing months into the following
groups: spring (April to June, 4 to 9°C), summer (July
to September, 11 to 14°C), autumn (October to No -
vem ber, 8 to 11°C) and winter (December to March,
1 to 7°C). Water temperatures tend to be highest in
August and September (12 to 14°C) and lowest in
February and March (1 to 2°C). Thirdly, a variable,
called season2, was created where season was dicho -
tomized based on months where water temperatures
were generally above or below 10°C. Water temper-
atures were generally above 10°C from July to Octo-
ber and below 10°C from November to June. For the
variable week, the baseline value was Week 2, corre-
sponding to Days 7 to 13 after the start of treatment.
Week 1 was eliminated from this part of the analysis
because there was usually no noticeable treatment
effect at this point (often there was an increase in
L. salmonis abundance, as noted in Fig. 2). As men-
tioned above, for both statistical models, the Grand
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Manan Island ABMAs 2b and 3b were grouped
together (Fig. 1).
For the linear model, upon initial examination of
the outcome variable (mean abundance of total mo -
biles), the data were found to be positively or right-
skewed. A Box-Cox analysis produced a lambda
value of 0.087. This led to logarithmic transformation
of the data by using the formula ln(mean + 0.1) to
help improve our statistical assumptions of normality
of residuals and homoscedasticity. Pre-treatment
abundance was also logarithmically transformed.
Predictor variables were initially screened uncondi-
tionally, and those with a p-value of <0.15 were re -
tained for model building. The linearity of the rela-
tionship between pre-treatment and post-treatment
(log) counts was evaluated using a locally weighted
scatterplot smoothing algorithm (Lowess) and found
to be acceptable. Initially, both treatments and farms
were considered random effects, but little un -
explained variation was found at the farm level;
therefore, a 2-level model (sampling weeks within
treatment episodes) was constructed. A Toeplitz co -
variance structure to account for correlations among
counts up to 6 wk apart was applied at the lowest
(week) level. Model building was carried out manu-
ally and interactions among key variables were eval-
uated as part of the process. Residuals at both the
week and treatment episode level were checked for
normality and homoscedasticity.
The second model was a logistic regression model
used to evaluate factors associated with treatment
success or failure. Success was defined as a minimum
of a 60% reduction in Lepeophtheirus salmonis bur-
dens at any point in the post-treatment period. The
outcome variable was treatment success or failure.
The predictor variables considered were year,
month, season, season2, location (ABMA), fish age,
season of smolt transfer and pre-treatment mean
L. salmonis abundance (log transformed). A multi-
level logistic model using treatments nested within
farms was initially assessed but there was little unex-
plained variation between farms; therefore, a simple
logistic regression model was used.
A similar model building process to the linear
mixed model was used to create the logistic regres-
sion model. The fit of the final model was evaluated
by using Hosmer-Lemeshow goodness-of-fit test.
Specific observations not fitting the model or having
undue influence on the model were evaluated by
generating Pearson and deviance residuals, and any
outlying values were examined. Influence of outliers
on the model was evaluated by generating leverage
and deltabeta values.
Software programs used to analyze data were
Microsoft Excel 2007 (Microsoft Canada) and Stata/
IC 12 (StataCorp LP). Microsoft Excel 2007 was used
to manage and format the data and to create the
mean abundance and efficacy graphs. Stata 12 was
used to perform the trend and efficacy analysis along
with the statistical models.
RESULTS
After excluding treatment episodes based on study
inclusion criteria, 114 treatment episodes across 54
farms remained in this analysis. There was a mean of
40 fish examined per sample (range, 10 to 240) and
4.3 cages selected per sample date (range, 1 to 19).
Trends in post-treatment lice abundance and
treatment effectiveness
The pre-treatment mean abundance of mobile
Lepeophtheirus salmonis varied over the 5 years
examined. In 2004, pre-treatment mean abundance
was 0.7 mobiles per fish and increased annually to
around 10 times this value by 2007 and 2008 (Fig. 2).
Based on an ANOVA procedure, year had a signifi-
cant (p < 0.01) influence on pre-treatment abun-
dance. Bonferroni multiple comparisons determined
that there were significant differences in pre-treat-
ment means between years 2004 and 2007 (p = 0.001)
and be tween 2004 and 2008 (p = 0.001), as well as
between 2005 and 2008 (p = 0.035). The difference
between 2005 and 2007 was marginally significant at
p = 0.056.
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Fig. 2. Mean abundance (±SE) of mobile sea lice Lepeoph-
theirus salmonis before (Pre-Tx) and after treatment with
emamectin benzoate on farmed Atlantic salmon in New 
Brunswick from 2004 to 2008
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The number of treatments per year and classifica-
tion of treatments by success or failure are listed in
Table 2. If the post-treatment mean abundance of
Lepeophtheirus salmonis fell to less than 40% of the
pre-treatment value at any point during the follow-
up period, then an individual treatment episode was
deemed effective. Effectiveness could not be calcu-
lated for episodes where pre-treatment abundance
was zero and this occurred in 2 treatment episodes,
one from 2004 and another from 2008. Both of the
treatments resulted in very low L. salmonis abun-
dance in the follow-up period, which ranged from 0
to 0.07 mobiles per fish in all weeks; therefore, these
treatments were classified as successful.
Treatment effectiveness declined through the years
examined. In 2004 and 2005, all treatments evaluated
were deemed effective, while through 2006 to 2008,
the number of ineffective treatments progressively
increased each year. In 2006, the first ineffective
treatment was noted and 2 other treatment episodes
were marginally effective (where the maximum ef-
fectiveness was 36.9% and 33.7% of the mean pre-
treatment abundance). Overall, 94 of 114 treatment
episodes, or 82%, were classified as effective for all
the years examined. The major change occurred be-
tween 2007 and 2008 when the percentage of suc-
cessful treatments decreased from 90 to 51%.
In 2007, 28 of 31 treatments were deemed effective
in this study, although only 20 treatments reached a
post-treatment abundance level of <1 mobile per
fish. In 2008, 17 of the 33 treatments were considered
effective based on the cut-off point of 40%; however,
only 14 of these treatments reached post-treatment
abundance of <1 mobile per fish.
The effectiveness of emamectin benzoate summa-
rized by year as a percentage of pre-treatment mean
abundance of Lepeophtheirus salmonis is demon-
strated in Fig. 3. All years, on average, exhibited
overall treatment success, except for 2008. However,
the maximum level of effectiveness attained de -
creased with each subsequent year. In 2004, the post-
treatment mean abundance fell to as low as 0.9% of
pre-treatment levels during the follow-up period,
while in 2005, maximum effectiveness was 6.8% of
the pre-treatment level. This effectiveness continued
to erode over the next 3 yr (15.3% for 2006, 22.6% for
2007 and 75.7% for 2008).
Duration of treatment effect varied between treat-
ment episodes, but in this study it appeared to last
approximately 9 to 10 wk during the early years
(Fig. 3). In 2004 and 2005, the trends were typical for
an effective treatment with emamectin benzoate
when the percentage of pre-treatment levels de -
creased to less than 20% by Week 3 and remained
relatively low for the following 7 wk. In 2006, there
was an expected drop in mobile Lepeophtheirus
salmonis following treatment, but effectiveness val-
ues did not stay low for as long as those seen in 2004
and 2005 as evidenced by an increase that began
around Week 8 after 2 to 3 wk of minimum values. By
2007, there appeared to be a steady rise in values
beginning around Week 6 or 7 after treatment. The
dramatic drop previously observed in the first
few weeks after treatment was absent in 2008.
Although just over 50% of treatment episodes were
deemed effective, treatments as a whole for that year
were classified as ineffective; this is evident in the
failure to drop below 75% in 2008 on Fig. 3. Overall,
duration of treatment effect appeared to decrease
with time.
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Year No. of qualifying treatments 
Total Effective (%) Ineffective
2004 7 7 (100) 0
2005 20 20 (100) 0
2006 23 22 (95.6) 1
2007 31 28 (90.3) 3
2008 33 17 (51.5) 16
Total 114 94 (82.5) 20
Table 2. Summary of qualifying emamectin benzoate treat-
ment episodes for sea lice Lepeophtheirus salmonis by year
and number of treatments that were effective or ineffective.
Effectiveness was defined as a reduction in lice burden to 
<40% of pre-treatment abundance
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Fig. 3. Trends in treatment effectiveness (as a percentage
of pre-treatment mean abundance of mobile sea lice) of
emamectin benzoate treatments against Lepeophtheirus
salmonis on farmed Atlantic salmon in New Brunswick from 
2004 to 2008
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Time to maximum effectiveness varied by treat-
ment episode and year. In the early years, maximum
treatment effect was generally attained between
Weeks 4 and 6 after the start of treatment (Fig. 3).
The time to maximum effect was extended to Week 7
in the final year of the study (2008).
Statistical modelling of post-treatment 
lice abundance
The linear mixed model was evaluated initially
using a 3-level model in which weeks were nested
within treatments and treatments were nested within
farms. There were 114 treatments spread over 54
farms resulting in a mean of 2.1 treatments per farm
(range was 1 to 5). We determined that the use of farm
as a random effect was not necessary given there was
little unexplained variation at the farm level, probably
because there were so few treatments per farm. As a
result, a 2-level model was used with weeks nested
within treatments. Treatment episodes were treated
as random effects. In the 2-level model, there was little
unexplained variation at the treatment level as all the
variation was explained by both the fixed parameters
and the unexplained variation by the covariance pat-
tern (Toeplitz correlation structure) at the lowest level
(week). The covariance estimates confirmed that
there was a high level of correlation among counts
collected close together (1 to 2 wk apart), but that this
declined steadily and there was no remaining correla-
tion once counts were more than 6 wk apart.
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Variable Category Coefficient (log- SE p 95% CI
transformed) Lower Upper
Year 2005 0.10 0.32 0.759 −0.53 0.73
2006 0.30 0.32 0.354 −0.33 0.93
2007 0.86 0.33 0.010 0.21 1.51
2008 1.60 0.34 0.000 0.94 2.26
Bay code (ABMA) Lime Kiln (2a) −0.41 0.24 0.087 −0.87 0.06
Grand Manan (2b and 3b) −1.09 0.18 0.000 −1.45 −0.73
Maces Bay (3a) −0.38 0.20 0.061 −0.78 0.02
Week 3 −0.66 0.07 0.000 −0.81 −0.52
4 −0.90 0.09 0.000 −1.08 −0.72
5 −1.15 0.10 0.000 −1.36 −0.95
6 −1.22 0.12 0.000 −1.46 −0.97
7 −1.23 0.13 0.000 −1.48 −0.98
8 −1.07 0.14 0.000 −1.34 −0.80
9 −0.80 0.15 0.000 −1.09 −0.51
10 −0.46 0.15 0.000 −0.76 −0.16
11 −0.26 0.16 0.111 −0.57 0.06
12 −0.07 0.18 0.686 −0.43 0.28
Season of transfer Autumn 0.16 0.28 0.572 −0.39 0.70
Fish age >365 d 0.28 0.16 0.076 −0.03 0.60
Fish age × season of transfer interaction 0.84 0.32 0.009 0.21 1.47
Pre-treatment abundance (log-transformed) 0.44 0.06 0.000 0.32 0.55
Constant −0.42 0.33 0.200 −1.06 0.22
Random effects parameters Estimate SE 95% CI
Lower Upper
Treatment: identity Variance (constant) 1.26 × 10−15
Residual: Toeplitz (6) Covariance1 0.76 0.07 0.62 0.91
Covariance2 0.61 0.07 0.48 0.74
Covariance3 0.47 0.06 0.35 0.58
Covariance4 0.30 0.05 0.20 0.39
Covariance5 0.22 0.04 0.14 0.29
Covariance6 0.10 0.03 0.05 0.15
Variance (e) 0.98 0.07 0.84 1.14
Table 3. Results of the linear mixed regression model of mean mobile sea lice Lepeophtheirus salmonis abundance (log trans-
formed) after treatment with emamectin benzoate at Atlantic salmon farms in New Brunswick from 2004 to 2008. Baseline 
values are: Year: 2004; Bay code: Passamaquoddy (1); Season of transfer: spring; Fish age: <1 yr; Week: 2
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Results of the linear mixed model are shown in
Table 3 as the log-transformed values. Results
showed that post-treatment mean Lepeophtheirus
salmonis abundance increased during the later years
of the study and significant differences were found
between 2004 and 2007 and between 2004 and 2008.
No significant differences were found between post-
treatment L. salmonis levels in ABMA 1 (Passa ma -
quoddy Bay) and ABMA 2a (Lime Kiln Bay) or
between ABMA 1 and ABMA 3a (Maces Bay). Levels
of L. salmonis abundance were significantly lower at
sites near Grand Manan Island (ABMAs 2b and 3b)
than at sites in Passamaquoddy Bay (ABMA 1).
Pre-treatment mean abundance of Lepeophtheirus
salmonis was a significant predictor in the level of
abundance during the post-treatment period. For
every increase in the pre-treatment abundance of 1
natural log value (equivalent to an increase by a fac-
tor of 2.7 times), there was a corresponding increase
in the post-treatment log-values of 0.44 (equivalent
to an increase by a factor of ~1.5 times).
There was a significant interaction between age of
fish and season of smolt transfer indicating that the
effects of fall transfer were different in second-year
fish compared with first-year fish. Ultimately, fish in
their second year and transferred to seawater in the
fall were more likely to have higher post-treatment
Lepeophtheirus salmonis abundance than second-
year fish that were transferred in the spring.
Statistical modelling of treatment outcome
A logistic regression model examined factors
involved with treatment outcome, classified as either
effective or ineffective treatments (Table 4). Since
there were no ineffective treatment episodes found
in either 2004 or 2005, those years were dropped
from this component of the analysis. The spring sea-
son was also dropped as it contained only 4 treatment
episodes (1 in 2006 and 3 in 2008), none of which
were classified as ineffective. Based on the exclusion
of the episodes from these years and season, a total of
83 treatment episodes were evaluated, which led to a
mean of 1.8 treatments per farming site.
Location of treatment was not significant in the full
model. However, the model was unable to estimate
the effect of predictor variables on treatment failure in
ABMAs 2b or 3b (Grand Manan Island) as there were
no failed treatments in the data set, even in 2008.
There appeared to be no significant differences in
treatment outcome between ABMAs 1, 2a and 3a. All
possible interactions between variables were evalu-
ated during the model-building process and none
were found to be significant. Fit of the model to the
data was evaluated by use of the Hosmer-Lemeshow
goodness-of-fit test; there was no evidence of lack of
fit. All potentially influential observations or outliers
were assessed and examined, and none were found to
have undue influence on the model.
In summary, this model showed that treatments
applied in 2008 had an increase in the odds of failure
by 37 times over a treatment applied in the year 2006.
Season was also a significant variable (p < 0.01);
treatments administered during autumn (October
and November) had an odds of failure approximately
7 times that of treatments applied during summer
months (July to September).
DISCUSSION
There are challenges commonly encountered when
using historical production data, some of which were
reviewed by Lees et al. (2008a). The challenges en -
countered in the present study were that numerous
individuals carried out the sea lice counts (lack of
consistency), pre-treatment counts occurred any time
within the 16 d period prior to treatment initiation
(true pre-treatment levels at treatment initiation may
have been higher than indicated) and treatment
episodes were excluded that did not meet the inclu-
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Variable Category Coefficient SE p Odds ratio 95% CI
Lower Upper
Year 2007 1.02 1.23 0.407 2.78 0.25 31.22
2008 3.63 1.18 0.002 37.64 3.72 380.22
Season Autumn 1.97 0.74 0.008 7.18 1.67 30.92
Pre-treatment abundance [ln(x + 0.1)] −0.24 0.26 0.357 0.79 0.47 1.31
Constant −3.91 1.15 0.001
Table 4. Results of logistic regression analysis of factors associated with ineffective emamectin  benzoate treatments for sea lice
Lepeophtheirus salmonis at salmon farms in New Brunswick from 2006 to 2008. Constant is baseline year 2006 in the 
summer season
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sion criteria. The use of a large data set helped to
improve the statistical power of this study. The data
set used in the present study was comparable in size
to that used by Lees et al. (2008a,b) but larger than
those used in similar previously published studies
(Gustafson et al. 2006, Saksida et al. 2010).
A concern with the use of historical data is the lack
of control groups as discussed in Gustafson et al.
(2006). Classic assessment of treatment efficacy in -
volves a study design in which the effect of treatment
is based on the differences between 2 groups ran-
domized to treatment or control, such as attempted
by Campbell et al. (2006). In the treatment of parasite
populations in the aquatic environment where dis-
ease progression is best controlled while in the early
stages, there are welfare concerns when leaving
cages of fish untreated with a growing sea lice infes-
tation. To assess the treatment effectiveness of ema -
mectin benzoate in a clinical environment that was
not amenable to the inclusion of untreated control
cages, treatment effects had to be based on the
change in sea lice populations after treatment com-
pared with the pre-treatment sea lice assessments.
This study relied on sea lice count data recorded by
the fish farmers whose routine management required
frequent enumeration of sea lice on Atlantic salmon.
Although fish are obtained using non-random sam-
ples (i.e. attracting fish to the surface with feed and
then capturing them with a hand net) and sampling
bias may have been introduced, there are no practi-
cal solutions for frequent random samples in the
salmon farming environment. Sampling practices
have been reviewed in a number of studies (Revie et
al. 2005, 2007, Heuch et al. 2011) and can be a pre-
cise method for detection of farm level sea lice infes-
tations. In field observational studies of sea lice pat-
terns, any selection bias associated with estimates of
the true mean sea lice abundance is assumed to be
present in similar levels across different treatment
events and thus inconsequential to the interpretation
of effectiveness.
In this study, pre-treatment Lepeophtheirus salmo-
nis abundance in the early years was lower than the
pre-treatment abundance in similar studies. In Lees
et al. (2008a), the pre-treatment mean L. salmonis
abundance ranged from approximately 5 to 15 mo -
biles per fish, while in Saksida et al. (2010) the range
was from approximately 4 to 7 mobiles per fish. In the
present study, pre-treatment values were, on aver-
age, fewer than 3.0 mobiles per fish for 2004 to 2006,
but in 2007 and 2008 they rose to 8.7 and 6.3 mobiles
per fish, respectively. The reason for this change
in pre-treatment L. salmonis abundance between
2004−2006 and 2007−2008 cannot be determined
with this study design. This observation may be asso-
ciated with increased L. salmonis tolerance for ema -
mectin benzoate (unable to maintain sufficient con-
trol over populations), natural variation in the levels
of L. salmonis found on farmed fish in that region or a
tendency by farm management to initiate treatment
decisions differently. Lees et al. (2008a) also ob served
differences in pre-treatment abundance between
years with higher abundance occurring in 2003 and
2004.
During the early years of the present study, dura-
tion of treatment effect appeared to last for approxi-
mately 9 to 10 wk after treatment initiation.  Similarly,
Lees et al. (2008a) found the lowest Lepeophtheirus
salmonis abundance between Days 21 and 62
(Weeks 4 and 9), with levels generally remaining
below pre-treatment levels for the full observation
period (83 d). We found the length of treatment effect
was reduced in later years. Development of tolerance
in L. salmonis to this compound may have been a fac-
tor, but one cannot rule out other possible variables,
such as increases in external infection pressure, sea-
sonal effects or lack of data in the later weeks of some
treatment episodes. Recent laboratory bioassay evi-
dence is suggestive of the development of decreased
sensitivity to emamectin benzoate in L. salmonis from
the Bay of Fundy over time (Igboeli et al. 2012). In
British Columbia, an assessment of emamectin ben-
zoate efficacy found that acceptable levels of post-
treatment abundance were maintained for at least
3 mo following treatment, with L. salmonis levels
remaining significantly below pre-treatment levels
as well as staying below the trigger level of ‘3 mobile
L. salmonis per fish’ used in British Columbia (Sak-
sida et al. 2010). The reason for this continued suc-
cess of emamectin benzoate treatments in British
Columbia is unknown, but may be influenced by the
large populations of wild Pacific salmon, which may
act as a refuge for sea lice sensitive to emamectin
benzoate. In addition, there are differences in how
farms are distributed between these areas; farms in
British Columbia are located over a larger area, while
in southwestern New Brunswick farms are more
densely concentrated in a smaller region. These dif-
ferences may play a role in the variation of L. salmo-
nis sensitivity between these 2 regions and warrant
further investigation.
Results for time to maximum effectiveness were
similar to those in other studies. In Lees et al. (2008a),
the lowest levels were found around Days 28 to 34
(Week 5) in the early years of the study, while
Gustafson et al. (2006) found a similar range of 21 to
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28 d (Week 4) for the maximum effect to be reached.
Maximum effectiveness was, on average, attained
between Weeks 4 and 6 from 2004 to 2007. In 2008,
maximum treatment effect was not evident until
Week 7 (75.7%). These trends were supported by
clinical observations that Lepeophtheirus salmonis
were remaining on fish longer after treatment admin-
istration when suspicions of tolerance development
first emerged (M. Moore pers. comm.).
The major finding from the results of the linear
mixed model for variables associated with post-treat-
ment mean abundance of Lepeophtheirus salmonis
was that treatment effect varied both temporally and
spatially. Post-treatment abundance increased from
2004 to 2008. In addition, there were differences by
location, and the areas farthest from the mainland at
Grand Manan Island (ABMAs 2b and 3b) had the
lowest L. salmonis burdens. Similar findings were
reported by Lees et al. (2008a). Variables related to
month or season of treatment application were non-
significant. The majority of treatment episodes (97 of
114) in this analysis occurred between July and Octo-
ber; consequently there were insufficient treatment
episodes spread throughout the year to support con-
clusions on the effects of season on post-treatment
abundance. Only one treatment met the inclusion
criteria during the winter season (December to
March) and this was an effective treatment in 2004.
One could speculate that we would expect to see
overall lower L. salmonis abundance around treat-
ment episodes during the winter months as sea lice
levels in New Brunswick tend to be lowest through-
out the winter (Chang et al. 2011). However, time to
maximum treatment effect may be delayed in winter,
as was shown in an efficacy study on ema mectin ben-
zoate that found treatments applied during colder
months took longer to reach maximum effect (Stone
et al. 2000c). In comparison, Lees et al. (2008a) found
some seasonal variations in the Scottish data in post-
treatment levels in which treatments applied during
winter (November to January) and spring (February
to April) had higher abundance of L. salmonis.
The frequency of treatments in young versus older
fish was almost equivalent with 59 treatments being
administered to fish less than 1 yr in sea cages and
55 treatments applied to fish having been in sea -
water for more than 1 yr. In New Brunswick, the
majority of salmon smolts are transferred in spring
as opposed to fall, and this was reflected in the data.
Of the 114 treatments, 88 were applied to spring-
transferred fish. In our analysis, the quantity of post-
treatment Lepeophtheirus salmonis abundance in
second-year fish depended upon whether these fish
were transferred in spring or fall. For example, in
2008, second-year fish had a notable increase in
modelled post-treatment abundance between spring
and fall transfers, which went from 1.89 to 5.31 mo -
bile L. salmonis per fish (for the sixth week following
treatment initiation in year 2008 in Passamaquoddy
Bay). There may be other explanatory factors con-
tributing to the significance of this interaction that
have not been explored in this study, such as the use
of emamectin benzoate in the freshwater hatchery
phase prior to transfer, proximity of other farms treat-
ing for sea lice, variation in fish size or the inability to
administer treatments due to inclement weather. A
linear regression model was also used by Lees et al.
(2008a) who similarly found that post-treatment
L. salmonis abundance was higher in second-year
fish. In general, L. salmonis abundance can be higher
during the second year of production at sea (Saksida
et al. 2007, Lees et al. 2008c).
In the logistic model, pre-treatment Lepeophthei -
rus salmonis abundance was forced into the model
due to the potential of being a confounding variable.
However, pre-treatment abundance was found to be
nonsignificant, indicating that pre-treatment levels
did not appear to be a determining variable for treat-
ment outcome. If a treatment was going to be unsuc-
cessful, it was going to happen regardless of L.
salmonis abundance prior to treatment application. A
similar result was found by Lees et al. (2008b) when
they examined the Scottish data. Likewise, Lees et al.
(2008b) found year and season to be significant vari-
ables in the logistic model with an in creased risk of
ineffective treatments occurring with time, and the
most marked increase was noted for the last year
examined (2006) in the Scottish data. In New
Brunswick, a notable increase in risk of failed treat-
ments occurred in the last year of the study (2008).
Furthermore, autumn treatments were at significant
risk of failure compared with treatments applied
 during the summer months. Again, there were in -
sufficient data available to evaluate the effects of
season on treatments applied during winter or spring
months.
This study found that ineffective treatments oc -
curred in all bays except those around Grand Manan
Island (ABMAs 2b and 3b). Grand Manan Island is
located 32 km south of Blacks Harbour, New
Brunswick. The closest mainland is the easternmost
point of Maine in the USA, close to the town of
Lubec, which is 15 km across the Grand Manan
Channel (see Fig. 1). Given the location, sea farms in
this area would be more exposed to the open ocean
than other locations closer to the New Brunswick
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mainland. These fish are exposed to different envi-
ronmental variables (farm density, tidal excursion,
current speeds), which may have resulted in lower
sea lice infection pressure than fish on farms close to
the New Brunswick mainland (Chang et al. 2011).
Farms in this region are physically farther away from
farms closer to the mainland and perhaps the resist-
ant sea lice had not migrated that far between farms,
or resistance had not yet developed locally from
repeated treatments leading to selection of ema -
mectin-resistant sea lice. There were more qualify-
ing treatment episodes on farms located in bays
closer to mainland New Brunswick (72 treatments in
ABMAs 1 and 2a versus 22 treatments in ABMAs 2b
and 3b). Because there were fewer treatments
applied around Grand Manan Island, there may have
been decreased selection pressure (i.e. selection of
resistant sea lice) in comparison with other areas.
Increased frequency of pesticide application is one of
the factors associated with development of parasiti-
cide resistance (Denholm et al. 2002).
The underlying cause of ineffective treatments
cannot be determined from this analysis. In the avail-
able treatment records reviewed for this study,
emamectin benzoate was found to account for >95%
of sea lice treatments applied from 2004 to 2008.
Although resistance to emamectin benzoate could be
the primary cause for treatment failure, other reasons
for reduced treatment efficacy, such as poor feed
ingestion by fish, improper application (not feeding
for full 7 d or missed treatment days due to inclement
weather) or inappropriate concentration or distribu-
tion of the drug within the feed may all contribute to
subtherapeutic dosing and potentially lead to iso-
lated treatment failures. Treatment failures can lead
to erroneous conclusions of resistance development.
In an effort to substantiate suspicions of a decay in
treatment effectiveness, this study em ployed epi-
demiological principles and a relatively large sample
size encompassing both time and location to investi-
gate this issue. Evidence presented in this study
shows a decline in treatment effectiveness, which is
suggestive of resistance development.
Changes in susceptibility of sea lice to emamectin
benzoate have been assessed by other methods, of
which the most common approach is the bioassay.
Bioassays have been used in New Brunswick (West-
cott et al. 2008), as well as in other salmon farming
regions around the world for monitoring sea lice sen-
sitivity to therapeutic agents (Sevatdal & Horsberg
2003, Sevatdal et al. 2005, Bravo et al. 2008). Westcott
et al. (2008) examined Lepeophtheirus salmonis sen-
sitivity to emamectin benzoate by bioassay from 2002
to early 2005 in samples collected in New Brunswick
and found no changes between regions or over time
by year. There were indications of decreased sensi-
tivity of L. salmonis to emamectin benzoate during
the fall and winter seasons. More recently, Igboeli
et al. (2012) found increases in EC50 values from
L. salmonis collected in 2011 compared with values
obtained by Westcott et al. (2008) from 2002 to 2005
suggesting the development emamectin benzoate
resistance had occurred over time.
In conclusion, this analysis presents evidence of a
reduction in emamectin benzoate treatment effec-
tiveness over time and between geographical loca-
tions for the period of time examined, 2004 to 2008.
These results correspond with the clinical picture
witnessed in the field of a decline in treatment effect,
which became a concern in 2008 (Chang et al. 2011).
Further investigation is warranted to confirm the
underlying cause of this decline in treatment effec-
tiveness. In addition, more collaboration is needed
between laboratory investigations of sea lice sensi-
tivity to treatment agents and epidemiological analy-
ses of treatment events and sea lice trends, which
would allow for a more holistic understanding of the
development of parasiticide resistance in the aquatic
environment.
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